title: Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies.
abstract: Several disease-monitoring techniques are available for the physician treating acute myeloid leukaemia (AML). Besides immunohistochemistry assisted light microscopy, the past 20 years have seen the development and preclinical perfection of a number of techniques, most notably quantitative polymerase chain reaction (PCR) and multicolor flow cytometry. Late additions to the group of applicable assays include next generation sequencing and digital PCR. In this review the principles of use of these modalities at three different time points during the AML disease course are discussed, namely at the time of treatment evaluation, pretransplantation and postconsolidation. The drawbacks and pitfalls of each different technique are delineated. The evidence or lack of evidence for minimal residual disease guided treatment decisions is discussed. Lastly, future strategies in the MRD field are suggested and commented upon.
authors.affiliation: Department of Hematology, Aarhus University Hospital, Tage-Hansens gade 2, Aarhus C, 8000, Denmark.
authors.forename: Hans Beier
authors.initials: HB
authors.lastname: Ommen
keywords: AML; Minimal residual disease; NGS; Preemotive treatment; flow cytometry; qPCR
references.citation: Blood. 2015 Feb 26;125(9):1367-76
references.pmid: 25550361
references.citation: Br J Haematol. 2012 Sep;158(5):569-80
references.pmid: 22738609
references.citation: Br J Haematol. 2009 Sep;146(6):669-74
references.pmid: 19650884
references.citation: Am J Clin Pathol. 2009 May;131(5):647-55
references.pmid: 19369623
references.citation: Br J Haematol. 2014 Jan;164(2):212-22
references.pmid: 24152218
references.citation: Haematologica. 2008 Jun;93(6):921-4
references.pmid: 18443273
references.citation: Haematologica. 2011 Oct;96(10):1568-70
references.pmid: 21750085
references.citation: Blood. 2003 Oct 15;102(8):2746-55
references.pmid: 12842988
references.citation: Best Pract Res Clin Haematol. 2010 Sep;23(3):379-90
references.pmid: 21112037
references.citation: Leukemia. 2005 Aug;19(8):1416-23
references.pmid: 15920493
references.citation: Nat Methods. 2013 Oct;10(10):1003-5
references.pmid: 23995387
references.citation: Mol Aspects Med. 2006 Apr-Jun;27(2-3):95-125
references.pmid: 16460794
references.citation: Br J Haematol. 2014 Jun;165(5):618-28
references.pmid: 24611505
references.citation: Lancet Oncol. 2010 Jun;11(6):543-52
references.pmid: 20451454
references.citation: N Engl J Med. 2014 Dec 25;371(26):2477-87
references.pmid: 25426838
references.citation: Cancer. 2011 Jun 15;117(12):2697-702
references.pmid: 21656747
references.citation: Cytometry B Clin Cytom. 2012 Jan;82(1):3-8
references.pmid: 22173921
references.citation: Eur J Haematol. 2013 Nov;91(5):394-8
references.pmid: 23772754
references.citation: J Chronic Dis. 1961 Dec;14:593-608
references.pmid: 13894982
references.citation: Leukemia. 2004 Aug;18(8):1380-90
references.pmid: 15201848
references.citation: Leukemia. 2014 Jan;28(1):129-37
references.pmid: 23958918
references.citation: Leukemia. 2012 Mar;26(3):381-9
references.pmid: 21886171
references.citation: Leuk Res. 2006 Apr;30(4):389-95
references.pmid: 16243396
references.citation: Haematologica. 2014 Mar;99(3):465-73
references.pmid: 24142997
references.citation: Cytometry B Clin Cytom. 2004 Nov;62(1):25-38
references.pmid: 15468339
references.citation: Blood. 2010 Jan 14;115(2):198-205
references.pmid: 19901261
references.citation: Leukemia. 2006 Nov;20(11):2051-4
references.pmid: 16990770
references.citation: Blood. 2013 May 16;121(20):4056-62
references.pmid: 23535063
references.citation: Leukemia. 2006 Jun;20(6):1103-8
references.pmid: 16541144
references.citation: Br J Haematol. 2008 Jun;141(6):782-91
references.pmid: 18410450
references.citation: Blood. 1995 Mar 15;85(6):1416-34
references.pmid: 7888664
references.citation: Leuk Res. 2015 Feb;39(2):138-43
references.pmid: 25498507
references.citation: Bone Marrow Transplant. 2015 May;50(5):642-51
references.pmid: 25665046
references.citation: Blood. 2010 Jan 21;115(3):453-74
references.pmid: 19880497
references.citation: Blood. 2010 Jul 22;116(3):354-65
references.pmid: 20385793
references.citation: Br J Haematol. 2004 Jun;125(5):590-600
references.pmid: 15147374
references.citation: Br J Haematol. 1999 Oct;107(1):69-79
references.pmid: 10520026
references.citation: J Clin Oncol. 2011 Jul 1;29(19):2709-16
references.pmid: 21555683
references.citation: Haematologica. 2004 Oct;89(10):1267-9
references.pmid: 15477217
references.citation: Blood. 2012 Oct 4;120(14):2826-35
references.pmid: 22875911
references.citation: Blood. 2010 Oct 14;116(15):2752-8
references.pmid: 20592250
references.citation: Eur J Haematol. 2011 Nov;87(5):400-8
references.pmid: 21707751
references.citation: Leukemia. 2007 Aug;21(8):1700-7
references.pmid: 17525725
references.citation: Nat Rev Clin Oncol. 2012 Oct;9(10):579-90
references.pmid: 22949046
references.citation: Leuk Res. 2004 Nov;28(11):1213-5
references.pmid: 15380347
references.citation: J Clin Oncol. 2013 Nov 1;31(31):3889-97
references.pmid: 24062400
references.citation: Semin Hematol. 2015 Jul;52(3):184-92
references.pmid: 26111465
references.citation: Blood. 2014 Nov 27;124(23):3345-55
references.pmid: 25049280
references.citation: Clin Cancer Res. 2006 Apr 15;12(8):2434-41
references.pmid: 16638849
references.citation: Exp Hematol. 2009 Jun;37(6):659-72
references.pmid: 19463768
references.citation: J Clin Oncol. 2011 Mar 20;29(9):1190-7
references.pmid: 21282535
references.citation: J Clin Oncol. 2013 Nov 10;31(32):4123-31
references.pmid: 24062403
references.citation: J Clin Oncol. 2003 Dec 15;21(24):4642-9
references.pmid: 14673054
references.citation: Eur J Haematol. 2015 Nov;95(5):436-41
references.pmid: 25605311
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5195-201
references.pmid: 19752335
references.citation: N Engl J Med. 2014 Dec 25;371(26):2488-98
references.pmid: 25426837
references.citation: Clin Cancer Res. 2015 Mar 15;21(6):1353-9
references.pmid: 25501127
references.citation: Leukemia. 2003 Dec;17(12):2318-57
references.pmid: 14562125
references.citation: Acta Haematol. 2004;112(1-2):79-84
references.pmid: 15179007
references.citation: J Clin Oncol. 2013 Sep 20;31(27):3360-8
references.pmid: 23940227
references.citation: Br J Haematol. 2014 Nov;167(4):478-86
references.pmid: 25371149
references.citation: Br J Haematol. 2013 Feb;160(4):503-9
references.pmid: 23294252